Presentations and webcasts

Register for our Alert Service to be notified whenever we add a presentation to our site.

Title Press Release Powerpoint Webcast
Interim Results 31 Dec 2016 pdf 2012blue  pdf 2012blue Webcast
AGM Presentation pdf 2012blue pdf 2012blue  
2015/16 Results Webcast pdf 2012blue pdf 2012blue Webcast
Interim Results 31 Dec 2015 pdf 2012blue pdf 2012blue Webcast
Moxatag Acquisition pdf 2012blue pdf 2012blue  
2014/15 Results Webcast pdf 2012blue pdf 2012blue Webcast
Tuzistra Approval   pdf 2012blue

 

H2 Interim Results Dec 2014  pdf 2012blue  

 

Interim Results June 2014 Webcast    

Webcast

2013 Results Webcast    

Webcast

Interim Results 2013 Webcast    

Webcast

2012 Results Webcast    

Webcast

Interim Results 2012 webcast    

Webcast

Note: To view PDF files, you will need the Adobe Acrobat Reader. This can be downloaded free of charge from the Adobe website.

Latest News

Unaudited Interim Results for the six months ended 31 December 2016

Vernalis plc (LSE: VER) today announces its unaudited consolidated results for the six month period ended 31 December 2016. 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch